Morphic to Present at November Investor Conferences
10 nov. 2023 08h00 HE
|
Morphic Therapeutic
WALTHAM, Mass., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
Morphic to Present at the Jefferies 2019 London Healthcare Conference
18 nov. 2019 16h15 HE
|
Morphic Therapeutic
WALTHAM, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious...
Minerva Neurosciences to Present at Jefferies London Healthcare Conference on November 21, 2019
14 nov. 2019 08h30 HE
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat...
Minerva Neurosciences to Present at Jefferies London Healthcare Conference on November 14, 2018
07 nov. 2018 08h30 HE
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat...